CD4 and neoplasm: The results from the TILs revealed a significantly stronger CD8+ T-cell tumor infiltration, a higher CD8+/CD4+ T-cell ratio, and higher CD8+ PD1−/Treg-cell ratio in the group of pIL12 GET.